Development of live, attenuated hepatitis A vaccine (H2-strain)

Hepatitis A, with high prevalence and high incidence, is one of the most serious infectious diseases in China. A programme aiming at developing a vaccine against hepatitis A has been in progress since 1980. The H2-strain vaccine that had been selected and studied in our laboratory was proven to be a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 1990-12, Vol.8 (6), p.523-524
1. Verfasser:	Mao, Jiangsen
Format:	Artikel
Sprache:	eng
Schlagworte:	China - epidemiology Hepatitis A - epidemiology Hepatitis A - prevention & control Hepatovirus - immunology Humans Vaccines, Attenuated - adverse effects Vaccines, Attenuated - pharmacology Vaccines, Attenuated - therapeutic use Viral Hepatitis Vaccines - adverse effects Viral Hepatitis Vaccines - pharmacology Viral Hepatitis Vaccines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Hepatitis A, with high prevalence and high incidence, is one of the most serious infectious diseases in China. A programme aiming at developing a vaccine against hepatitis A has been in progress since 1980. The H2-strain vaccine that had been selected and studied in our laboratory was proven to be attenuated for human beings and has been proven to be effective in preventing hepatitis A. In the near future, the live, attenuated H2-strain vaccine derived from tissue culture will be available in China.
ISSN:	0264-410X 1873-2518
DOI:	10.1016/0264-410X(90)90001-3